Foldax, Inc. is an award-winning medical device company headquartered in Salt Lake City, Utah. The company specializes in the development and manufacturing of innovative Tria heart valves.
Subscribe to see Foldax, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Foldax, Inc. is a medical devices company headquartered in United States. It has raised at least $38.5M across the 8 funding rounds on record, 7 of them with a disclosed amount. Its most recent funding round raised $7M in October 2023. Xcout tracks 6 named people at Foldax, Inc., including Alex Andrianopoulos (CEO (Interim)).
At least $38.5M raised across the 8 rounds on record (7 with a disclosed amount). The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7M | — | |
| SEC Form D filing | $15M | — | |
| SEC Form D filing | $10.3M | — | |
| SEC Form D filing | $300,000 | — | |
| SEC Form D filing | $3.1M | — | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Foldax, Inc.'s closest competitors — see the full list of competitors and alternatives →
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
TRiCares is a medical device company with global offices that designs and develops specialized structural heart treatments and catheter-based valve repair systems.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Pi-Cardia is an Israeli medical-device company developing catheter-based therapies for calcific aortic valve stenosis. Its Leaflex system is designed to modify or fracture calcified aortic-valve leaflets, primarily serving patients with severe aortic stenosis and the physicians who treat them.
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.